$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Systemic delivery of polypeptides through the eye 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-037/26
  • A61K-037/64
  • A61K-047/00
출원번호 US-0412979 (1989-09-26)
발명자 / 주소
  • Chiou George C. Y. (College Station TX)
출원인 / 주소
  • Orbon Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 50  인용 특허 : 0

초록

Compositions and methods for systemic delivery of polypeptides through the eyes are disclosed. The compositions include a systemically active polypeptide at a concentration such that the composition is substantially isotonic with tear fluid. The compositions may include a permeation-enhancing agent

대표청구항

A method for delivering a polypeptide drug systemically, said method comprising: administering a therapeutically effective concentration of the drug formulated in a pharmaceutically acceptable vehicle into the eye, said concentration being less than 10% w/v and the volume of the drug formulation is

이 특허를 인용한 특허 (50)

  1. Cai Sui Xiong (Irvine CA) Keana John F. W. (Eugene OR) Weber Eckard (Laguna Beach CA), 1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes.
  2. Maggio, Edward T., Absorption enhancers for intranasal administration.
  3. Maggio, Edward T., Absorption enhancers for intranasal interferon administration.
  4. Cartt, Steve; Medeiros, David; Gwozdz, Garry Thomas; Loxley, Andrew; Mitchnick, Mark; Hale, David; Maggio, Edward T., Administration of benzodiazepine compositions.
  5. Cartt, Steve; Medeiros, David; Gwozdz, Garry Thomas; Loxley, Andrew; Mitchnick, Mark; Hale, David; Maggio, Edward T., Administration of benzodiazepine compositions.
  6. Arnold, John Jefferson; Huang, Chun Ming; Meezan, Elias; Pillion, Dennis J.; Tang, De Chu C., Alkyl-glycoside enhanced vaccination.
  7. Maggio, Edward T., Alkylglycoside compositions for drug administration.
  8. Yamada Minoru (Kawanishi JPX) Heya Toshiro (Takarazuka JPX) Ogawa Yasuaki (Otokuni-gun JPX), Biodegradable high-molecular polymers, production and use thereof.
  9. Kuo, Mei-Chang; Lechuga-Ballesteros, David, Compositions comprising an active agent.
  10. Kuo, Mei-chang; Lechuga-Ballesteros, David, Compositions comprising an active agent.
  11. Kuo,Mei chang; Lechuga Ballesteros,David, Compositions comprising an active agent.
  12. Maggio, Edward T., Compositions for drug administration.
  13. Maggio, Edward T., Compositions for drug administration.
  14. Maggio, Edward T., Compositions for drug administration.
  15. De Bruijn, Chris; Christ, F. Richard; Dziabo, Anthony J.; Vigh, Joseph, Contact lens and opthalmic solutions.
  16. Kensil Charlotte A. (Milford MA) Soltysik Sean (Worcester MA) Marciani Dante J. (Birmingham AL) Recchia Joanne (Blackstone MA), Drug delivery enhancement via modified saponins.
  17. Kuo, Mei-Chang; Lechuga-Ballesteros, David, Dry powder compositions having improved dispersivity.
  18. DiPerna, Paul M, Flow regulating stopcocks and related methods.
  19. Barbara H. O'Connor ; James Q. Oeswein, Human growth hormone aqueous formulation.
  20. O'Connor Barbara H. ; Oeswein James Q., Human growth hormone aqueous formulation.
  21. O'Connor Barbara H. ; Oeswein James Q., Human growth hormone aqueous formulation.
  22. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  23. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  24. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  25. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  26. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  27. Rosenkoetter Hans,DEX, Method for enhancing corneal penetration by water soluble ophthalmic drugs.
  28. Gardner, Thomas W.; Reiter, Chad E., Method of treating a nerve-related vision disorder in a non-diabetic subject.
  29. Kensil Charlotte A. (Milford MA) Soltysik Sean (Worcester MA) Marciani Dante J. (Hopkinton MA), Methods for enhancing drug delivery with modified saponins.
  30. Gardner, Thomas W.; Reiter, Chad E., Methods of treating nerve-related vision disorders by an insulinomimetic agent.
  31. Smith, Francis X.; Tracey, John Randall, Ophthalmic and contact lens solution.
  32. Smith, Francis X., Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers.
  33. Smith, Francis X., Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers.
  34. Smith, Francis X., Ophthalmic and contact lens solutions using low molecular weight amines.
  35. Smith, Francis X., Ophthalmic contact lens solutions containing forms of vitamin B.
  36. Smith, Francis X., Ophthalmic contact lens solutions containing forms of vitamin B.
  37. Smith, Francis X., Ophthalmic contact lens solutions containing forms of vitamin B.
  38. Sato, Takao; Uchida, Rei; Uno, Kenji, Ophthalmic lenses capable of sustained drug release and preservative solutions therefor.
  39. Gardner,Thomas W.; Reiter,Chad E., Periocular drug delivery for diabetic retinopathy.
  40. Maggio, Edward T., Pharmaceutical composition including alkyl glycoside and an anti-seizure agent.
  41. Kraft, Edward R.; Kulp, Gabriela A.; Godley, Bernard F.; Koutrouvelis, Aristides P., Photokinetic ocular drug delivery methods and apparatus.
  42. Auten Richard D. (5960 Rolling Oaks La. Cumming GA 30130) Heyl Barbara L. (401 Glenwood Ave. Atlanta GA 30312), Process for sterilizing articles and providing sterile storage environments.
  43. DiPerna, Paul M., Slideable flow metering devices and related methods.
  44. Brown, David, Solute concentration measurement device and related methods.
  45. Maggio, Edward T., Stabilizing alkylglycoside compositions and methods thereof.
  46. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
  47. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
  48. Simó Canonge, Rafael; Hernández Pascual, Cristina; Fernández Carneado, Jimena; Gómez Caminals, Marc; Jordana I Lluch, Rlbera; Farrera Sinfreu, Josep; Ponsati Obiols, Berta, Topical ophthalmic peptide formulation.
  49. Sakai Michinori,JPX ; Ohtake Hiroshi,JPX ; Azuma Hidekazu,JPX ; Otagiri Masaki,JPX ; Imai Teruko,JPX, Transmucous absorption enhancer.
  50. DiPerna, Paul M., Two chamber pumps and related methods.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로